Author

C. G. Banda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

D. G. Lalloo· 1 shared D. J. Terlouw· 1 shared F. K. Dzinjalamala· 1 shared J. Mallewa· 1 shared M. Mukaka· 1 shared S. Khoo· 1 shared V. Maiden· 1 shared V. Mwapasa· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

D. G. Lalloo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in falciparum-negative HIV-infected Malawian adults stabilized on antiretroviral therapy

C. G. Banda, F. K. Dzinjalamala, M. Mukaka, J. Mallewa, V. Maiden, D. J. Terlouw, D. G. Lalloo, S. Khoo, V. Mwapasa

This study evaluates how different antiretroviral therapies affect lumefantrine pharmacokinetics and the safety of artemether-lumefantrine in HIV-infected adults, finding significant variations in lumefantrine exposure and safety profiles.

bioRxiv · Jun 3, 2018Pharmacology & Toxicology